中图分类号:
R737.25
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 戴波,常坤,孔蕴毅,等. 根治性前列腺切除术后患者生化复发的危险因素分析[J]. 中华外科杂志,2015,53(4):261-265.
[2] 瞿元元,戴波.前列腺癌根治术后生化复发的危险因素[J].现代泌尿外科杂志,2013,18(2):204-206.
[3] GAJJJAR K,MARTIN-HIRSCH PL,MARTIN FL.CYP1B1 and hormone-induced cancer[J].Cancer Lett,2012,324(1):13-30.
[4] GO RE,HWANG KA,CHOI KC.Cytochrome P4501 family and cancers[J].J Steroid Biochem Mol Biol,2015,147:24-30.
[5] 顾成元,李巧新,朱耀,等.脂联素基因多态性与前列腺癌发病风险的相关性研究[J].中华泌尿外科杂志,2014,35(5):395-396.
[6] HOLT SK,KWON EM,FU R,et al.Association of variants in estrogen related pathway genes with prostate cancer risk[J].Prostate,2013,73(1):1-10.
[7] CATSBURG C,JOSHI AD,CORRAL R,et al.Polymorphisms in carcinogenmetabolism enzymes,fish intake,and risk of prostate cancer[J].Carcinogenesis,2012,33(7):1352-1359.
[8] FUKATSU T,HIROKAWA Y,ARAKI T,et al.Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population[J].Anticancer Res,2004,24(4):2431-2437.
[9] YANG J,XU DL,LU Q,et al.Prostate cancer risk and aggressivenessassociated with the CYP1B14326C/G (Leu432Val) polymorphism:a meta-analysis of 2788 cases and 2968 controls[J].Asian J Androl,2012,14(4):560-565.
[10] GU CY,LI GX,ZHU Y,et al.A single nucleotide polymorphism in CYP1B1 leads to differential prostate cancer risk and telomere length[J].J Cancer,2018,9(2):269-274.
[11] BEUTEN J,GELFOND JA,BYRNE JJ,et al.CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians[J].Carcinogenesis,2008,29(9):1751-1757.
[12] CHANG I,MITSUI Y,KIM SK,et al.Cytochrome P4501B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation[J].Oncotarget,2017,8(24):39087-39100.
[13] KWON YJ,BAEK HS,YE DJ,et al.CYP1B1 Enhances cell proliferation and metastasis through induction of EMT and activation of Wnt/β-catenin signaling via Sp1 upregulation[J].PLoS One,2016,11(3):e0151598.
[14] RICHMOND O,GHOTBADDNI M,ALLEN C,et al.The aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cells[J].PLoS One,2014,9(4):e95058.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家自然科学基金(81702537)
{{custom_fund}}